General MedicationsORALGeneric

VALSARTAN; HYDROCHLOROTHIAZIDE

Standard Dose

160MG; 25MG

Max Dose

Refer to approved labeling

Primary Use

Marketing status: None (Tentative Approval)

Summary

Approval overview VALSARTAN; HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 091654 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient VALSARTAN; HYDROCHLOROTHIAZIDE Form and strength TABLET; ORAL - 160MG; 25MG Sponsor TORRENT PHARMS LTD Submission history Latest submission status date: 2012-04-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview VALSARTAN; HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 091654 (ANDA). Marketing status: None (Tentative Approval) Active ingredient VALSARTAN; HYDROCHLOROTHIAZIDE Form and strength TABLET; ORAL - 160MG; 25MG Sponsor TORRENT PHARMS LTD Submission history Latest submission status date: 2012-04-10 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: None (Tentative Approval)

Interaction Notes

No interaction notes stored yet.